newsfilter
← Latest News
Business Wire·

BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights

- Announced agreement to be acquired by GSK for US$14.75 per share of common stock in cash representing an approximate total equity value of US$2.0 billion and a premium of approximately 103%; transaction expected to